Alkermes Plc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Alkermes Plc 's ROA in the third quarter of 2026?
Alkermes Plc recorded a cumulative net loss of $0 million during 12 months ending in the third quarter of 2026, resulting in a negative return on assets (ROA) of -0.01%.

However, within the Healthcare sector 210 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2026 from 650 to 1111.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	90.41 %	95.01 %	105.79 %	26.05 %	12.46 %
Y / Y Net Income Change	-80.32 %	-99.42 %	-	-66.32 %	-10.41 %
Net Income (TTM) in million	0	66	153	242	339
Return On Assets (TTM)	-0.01 %	1.96 %	5.38 %	10.56 %	15.69 %
ALKS's Total Ranking	# 1111	# 650	# 337	# 304	# 307
Total Assets (TTM) in million	4,436	4,393	4,284	2,487	2,330
Seq. Total Assets Change	0.97 %	2.54 %	72.27 %	6.76 %	3.4 %
Seq. Net Income Change	3150.9 %	-	-	-40.38 %	-4.98 %

ALKS's 5 Years Annual ROA >> Back to ALKS Management Effectiveness >> Compare ALKS ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 70
Sector	# 211
Overall	# 2532

Return On Assets Statistics
High	Average	Low
19.91 %	-2.01 %	-15.03 %
(Mar 31 2024)		(Jun 30 2016)

Financial Statements
Alkermes Plc 's Assets	$ 4,436 million	ALKS's Balance sheet
Alkermes Plc 's Income	$ 16 million	Quarterly ALKS's Income Statement
ALKS's Income by Division		See ALKS's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	26.06 %	-3.68 %	10.67 %	-3.13 %	4.93 %
Total Assets in million	2,487	1,973	2,048	1,851	1,911
Y / Y Net Income Change	-34.16 %	3.18 %	-	-	-
Net Income in million	242	367	356	-158	-48
Annual Return On Assets	9.72 %	18.6 %	17.37 %	-8.55 %	-2.52 %

ALKS's 5 Years Annual ROA >> Back to ALKS Management Effectiveness >> Compare ALKS ROA to its Competitors

Comment on ALKS's ROA in the fiscal year ending 2025

In the fiscal year 2025 Alkermes Plc 's ROA decreased compared to previous year to 9.72 %, due to deterioration of net income -34.16 % to $241.66 million, from $367.07 million a year ago, as ALKS's assets were $2,487.14 million.

More Return On Assets Ratios
ALKS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ALKS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ALKS's Competitors
Subscribers only: Roa for Alkermes Plc 's Suppliers
Subscribers only: Return On Assets for ALKS's Customers

You may also want to know
ALKS's Roi	ALKS's Inventory Turnover Ratio	ALKS's Growth Rates	ALKS's Dividend Comparisons
	ALKS's Profitability Ratios	ALKS's Asset Turnover Ratio	ALKS's Dividend Growth
ALKS's Roe	ALKS's Valuation Ratios	ALKS's Financial Strength Ratios	ALKS's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector

ROA

Date modified: 2026-11-06T12:59:29+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.